Burford Brothers’s Bristol-Myers Squibb BMY Stock Holding History

Burford Brothers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35M	Buy	23,457 +15,897	+210%	+$913K	0.5%	44
2026 Q1	$459K	Buy	7,560 +31	+0.4%	+$1.81K	0.19%	108
2025 Q4	$406K	Buy	7,529 +805	+12%	+$38.7K	0.17%	114
2025 Q3	$303K	Sell	6,724 -7	-0.1%	-$327	0.13%	131
2025 Q2	$312K	Buy	6,731 +5	+0.1%	+$245	0.14%	125
2025 Q1	$410K	Buy	6,726 +6	+0.1%	+$350	0.2%	108
2024 Q4	$380K	Sell	6,720 -78	-1%	-$4.36K	0.19%	113
2024 Q3	$352K	Hold	6,798	–	–	0.18%	114
2024 Q2	$282K	Hold	6,798	–	–	0.16%	125
2024 Q1	$369K	Hold	6,798	–	–	0.24%	109
2023 Q4	$349K	Buy	+6,798	New	+$357K	0.25%	104

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Burford Brothers's BMY Position: Q2 2026 in Review

Burford Brothers increased its Bristol-Myers Squibb (BMY) stake by 210% in Q2 2026, buying an estimated $913K and bringing the position to 23,457 shares worth $1.35M. The position accounts for 0.5% of the portfolio, ranked #44.

Burford Brothers first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Burford Brothers held 23,457 shares of Bristol-Myers Squibb worth $1.35M as of Q2 2026.
Burford Brothers bought 15,897 Bristol-Myers Squibb shares in Q2 2026, an estimated $913K.
Bristol-Myers Squibb made up 0.5% of Burford Brothers's portfolio in Q2 2026, its #44 holding.
Burford Brothers first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Burford Brothers's 13F filing for Q2 2026, filed 28 Jul 2026.